Qubit Pharmaceuticals, a company specializing in the discovery of new drug candidates using simulation and AI accelerated by hybrid HPC and quantum computing, and Institut Curie, France’s leading center in the fight against cancer, have announced their collaboration in the search for new therapeutic avenues to treat cancer. The project will be carried out in partnership with the Laboratoire de Microbiologie Fondamentale et Pathogénicité at the University of Bordeaux.